Procept Biorobotics Corp (PRCT) - Total Assets
Based on the latest financial reports, Procept Biorobotics Corp (PRCT) holds total assets worth $511.54 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Procept Biorobotics Corp to assess how comfortably operating cash covers total debt obligations.
Procept Biorobotics Corp - Total Assets Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's total assets have evolved over time, based on quarterly financial data. See Procept Biorobotics Corp net assets for net asset value and shareholders' equity analysis.
Procept Biorobotics Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Procept Biorobotics Corp's total assets of $511.54 Million consist of 90.2% current assets and 9.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 62.5% |
| Accounts Receivable | $83.50 Million | 15.6% |
| Inventory | $56.17 Million | 10.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $932.00K | 0.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PRCT market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Procept Biorobotics Corp's current assets represent 90.2% of total assets in 2024, an increase from 81.2% in 2019.
- Cash Position: Cash and equivalents constituted 62.5% of total assets in 2024, down from 67.8% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 15.6% of total assets.
Procept Biorobotics Corp Competitors by Total Assets
Key competitors of Procept Biorobotics Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Procept Biorobotics Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.43 | 6.02 | 7.59 |
| Quick Ratio | 7.19 | 5.07 | 7.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $400.31 Million | $269.33 Million | $95.73 Million |
Procept Biorobotics Corp - Advanced Valuation Insights
This section examines the relationship between Procept Biorobotics Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.08 |
| Latest Market Cap to Assets Ratio | 1.95 |
| Asset Growth Rate (YoY) | 31.9% |
| Total Assets | $534.02 Million |
| Market Capitalization | $1.04 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Procept Biorobotics Corp's assets above their book value (1.95x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Procept Biorobotics Corp's assets grew by 31.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Procept Biorobotics Corp (2019–2024)
The table below shows the annual total assets of Procept Biorobotics Corp from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $534.02 Million | +31.95% |
| 2023-12-31 | $404.72 Million | +30.84% |
| 2022-12-31 | $309.33 Million | -8.22% |
| 2021-12-31 | $337.02 Million | +167.54% |
| 2020-12-31 | $125.97 Million | +103.20% |
| 2019-12-31 | $61.99 Million | -- |
About Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more